Kurtzman, MD, is an advisor and investor with over 30 years of experience in operations and venture capital, focused on applying technology to solve healthcare's big problems.
Kurtzman has invested in and advised several health tech companies, with a focus on chronic disease management, personalized medicine, and the use of data and AI.
Kurtzman currently serves on the boards of NuvoAir, MedCrypt, Prenosis, and Oncora Medical, is a venture advisor to Chasm Partners, and teaches healthcare entrepreneurship at the Wharton School.
Kurtzman previously served as an advisor to Sibly (2022–2023) and is an advisor to Surgo Health (2023–Present), reflecting ongoing involvement in health technology ventures.
Kurtzman earned a BS in Biology from Stanford University and is an MD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices